QA – Page 29 – Pharma.Tips

Cross-Contamination Deviation Case Study: Allergen or Hormonal Product Residue

Examining Cross-Contamination Deviations: Addressing Allergen or Hormonal Product Residue Cross-contamination in pharmaceutical manufacturing remains a pressing challenge, especially when it involves residues from allergens or hormones that could lead to…

Shared Facility Controls for Maintenance and Engineering Activities

Effective Controls for Maintenance and Engineering Activities in Shared Facilities In pharmaceutical manufacturing settings where shared facilities are utilized, maintaining the integrity of products across multiple processes is paramount. Issues…

Cleaning and Cross-Contamination Review During Product Recall Assessment

Understanding and Managing Cleaning and Cross-Contamination Deviations During Product Recall Assessments In the pharmaceutical sector, maintaining the integrity of products and processes is critical. When a deviation occurs related to…

How to Define Acceptable Carryover in Shared Facilities

Guidelines for Effective Management of Acceptable Carryover in Multi-Product Facilities In the context of shared facilities, managing acceptable carryover (ACO) is critical to ensure product quality and patient safety. This…

Cross-Contamination Risk from Poor HVAC Pressure Cascade During Cleaning

Managing Cross-Contamination Risks Due to Inadequate HVAC Pressure Cascades During Cleaning Operations In the pharmaceutical manufacturing landscape, maintaining a clean environment is paramount to assuring product quality and compliance. One…

Shared Facility Risk Review During Annual Product Quality Review

Risk Management Strategies for Shared Facilities in Annual Product Quality Reviews In the realm of pharmaceutical manufacturing, shared facilities present unique challenges, particularly in risk management during the Annual Product…

How to Manage Cross-Contamination Risk During Equipment Breakdown

Managing Cross-Contamination Risk Following Equipment Breakdown Equipment breakdown in pharmaceutical manufacturing can lead to significant concerns, particularly regarding cross-contamination. When equipment fails, it jeopardizes the integrity of the products being…

How to Prevent Cross-Contact Between Product Families in Shared Sites

Strategies to Mitigate Cross-Contact Risks in Multi-Product Pharmaceutical Facilities In the dynamic landscape of pharmaceutical manufacturing, especially in shared facilities, cross-contact between different product families poses a significant risk to…

Cleaning Deviation From Shared Vacuum or Transfer System Residues

Addressing Cleaning Deviations from Shared Vacuum or Transfer System Residues in Pharmaceuticals Contamination control is a critical aspect of pharmaceutical manufacturing, ensuring that products are safe, effective, and compliant with…

Shared Facility Controls for Liquid and Powder Product Areas

Effective Management of Shared Facilities for Liquid and Powder Products The complexities of managing shared pharmaceutical facilities—especially in the case of liquid and powder products—can lead to significant contamination risks…

Cross-Contamination Deviation From Improper Cleaning Tool Storage

Cross-Contamination Issues Due to Improper Cleaning Tool Storage In pharmaceutical manufacturing, cross-contamination can lead to significant quality issues and regulatory scrutiny. One common source of contamination arises from improper storage…

How to Use Risk-Based Sampling in Shared Facilities

Implementing Risk-Based Sampling Strategies for Shared Facilities in Pharma Manufacturing In multi-product pharmaceutical manufacturing environments, managing risks associated with contamination is paramount. The challenge of implementing effective cross-contamination controls in…